A detailed history of Advisory Services Network, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Advisory Services Network, LLC holds 3,127 shares of CRL stock, worth $612,172. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,127
Previous 3,127 -0.0%
Holding current value
$612,172
Previous $645,000 4.65%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$206.39 - $268.73 $57,376 - $74,706
-278 Reduced 8.16%
3,127 $645,000
Q1 2024

May 06, 2024

BUY
$203.52 - $273.43 $92,194 - $123,863
453 Added 15.35%
3,405 $922,000
Q4 2023

Feb 09, 2024

SELL
$164.52 - $238.84 $14,642 - $21,256
-89 Reduced 2.93%
2,952 $697,000
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $28,582 - $31,988
-147 Reduced 4.61%
3,041 $595,000
Q2 2023

Aug 09, 2023

BUY
$183.71 - $210.25 $521,736 - $597,110
2,840 Added 816.09%
3,188 $670,000
Q1 2023

May 17, 2023

SELL
$191.89 - $259.92 $1,151 - $1,559
-6 Reduced 1.69%
348 $70,000
Q4 2022

Feb 13, 2023

BUY
$197.11 - $250.07 $69,776 - $88,524
354 New
354 $77,000
Q2 2022

Aug 02, 2022

SELL
$204.13 - $302.4 $425,202 - $629,899
-2,083 Closed
0 $0
Q1 2022

May 23, 2022

SELL
$255.51 - $362.11 $112,168 - $158,966
-439 Reduced 17.41%
2,083 $592,000
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $150,742 - $192,483
-429 Reduced 14.54%
2,522 $950,000
Q3 2021

Nov 05, 2021

SELL
$372.64 - $458.3 $41,363 - $50,871
-111 Reduced 3.63%
2,951 $1.22 Million
Q2 2021

Aug 12, 2021

SELL
$294.17 - $371.65 $16,179 - $20,440
-55 Reduced 1.76%
3,062 $1.13 Million
Q4 2020

Feb 09, 2021

SELL
$222.0 - $252.62 $121,878 - $138,688
-549 Reduced 14.98%
3,117 $779,000
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $393,605 - $507,700
2,242 Added 157.44%
3,666 $829,000
Q2 2020

Aug 10, 2020

SELL
$118.84 - $189.72 $16,043 - $25,612
-135 Reduced 8.66%
1,424 $248,000
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $149,734 - $270,006
1,514 Added 3364.44%
1,559 $197,000
Q4 2019

Feb 04, 2020

SELL
$126.05 - $152.76 $11,470 - $13,901
-91 Reduced 66.91%
45 $7,000
Q2 2019

Aug 01, 2019

BUY
$123.4 - $148.55 $16,782 - $20,202
136 New
136 $0
Q1 2019

May 20, 2019

SELL
$104.82 - $146.73 $5,555 - $7,776
-53 Closed
0 $0
Q4 2018

Feb 15, 2019

SELL
$105.09 - $137.23 $36,571 - $47,756
-348 Reduced 86.78%
53 $6,000
Q3 2018

Nov 02, 2018

BUY
$112.11 - $134.54 $44,956 - $53,950
401 New
401 $54,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.